0001878894-21-000003.txt : 20211004 0001878894-21-000003.hdr.sgml : 20211004 20211004162800 ACCESSION NUMBER: 0001878894-21-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211001 FILED AS OF DATE: 20211004 DATE AS OF CHANGE: 20211004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COLA MICHAEL F CENTRAL INDEX KEY: 0001188940 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 211303149 MAIL ADDRESS: STREET 1: 435 DEVON PARK BUILDING 800 CITY: WAYNE STATE: PA ZIP: 19087-1945 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Cerecor Inc. DATE OF NAME CHANGE: 20111102 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-10-01 0001534120 Avalo Therapeutics, Inc. AVTX 0001188940 COLA MICHAEL F C/O AVALO THERAPEUTICS, INC. 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 2.25 2021-10-01 4 A 0 78116 0 A 2021-10-01 2031-10-01 Common Stock 78116 78116 D 100% of this stock option will immediately vest on the date that it is granted. If employment is terminated prior to the end of the calendar quarter in which the option was granted, the number of shares underlying such stock option that reflects the percentage of calendar days remaining in such calendar quarter after such employment termination date shall be forfeited and deemed cancelled. /s/ Christopher R. Sullivan, by Power of Attorney 2021-10-04